Insights on Discovery
-
Distribution Of Standard-Of-Care Antituberculosis Drugs In Cynomolgus Macaque Lungs
4/23/2025
Incorporate individual variability into PBPK models and build on HRZE lung distribution data in NHPs to optimize anti-TB dosing strategies and advance PK/PD research in tuberculosis.
-
Multimodal Stratification Of Predictive Biomarkers In Head And Neck Cancers
4/23/2025
By identifying and utilizing predictive biomarkers, learn how researchers can enhance the effectiveness and safety of cytokine-based immunotherapy in head and neck cancers.
-
Uncovering Novel Therapeutic Targets In Immune Checkpoint Inhibitor Resistance
4/23/2025
Use spatial proteomics and AI-driven cell segmentation to reveal tumor-immune interactions and discover new targets to overcome resistance to immune checkpoint inhibitors in metastatic cancer.
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform
4/22/2025
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Time: A Crucial Factor In Therapeutics Development
4/21/2025
Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.
-
AAV Vectors In Gene Therapy Clinical Trials
4/16/2025
AAV-based gene therapies show promise but face immune challenges. ELISpot assays help evaluate T cell responses, enhancing clinical trial design and improving therapeutic success.
-
Extractables And Leachables Assessment For Single-Use Systems
4/14/2025
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
-
A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here
4/10/2025
Groundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.
-
Using AI-Analysis And High-Content Screening To Improve Data Capturing
4/4/2025
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
-
A Study To Assess Organoid Size And Cell Count From 3D Image Analysis
4/4/2025
Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.